Effects of dorzolamide/timolol fixed combination on retrobulbar hemodynamics in pseudoexfoliative glaucoma
- PMID: 26853174
- PMCID: PMC11916714
- DOI: 10.1016/j.kjms.2015.12.004
Effects of dorzolamide/timolol fixed combination on retrobulbar hemodynamics in pseudoexfoliative glaucoma
Abstract
In our study we aimed to evaluate the short-term effects of dorzolamide/timolol on ocular perfusion pressure and retrobulbar blood flow in patients with pseudoexfoliative glaucoma (PXG). This prospective observational cross-sectional study enrolled 22 eyes of 22 newly-diagnosed patients with PXG in a single center. All of the patients received a fixed combination of dorzolamide/timolol. Besides routine ophthalmologic examination, the retrobulbar hemodynamic parameters in the ophthalmic artery, central retinal artery, and short posterior ciliary arteries were measured in all participants at baseline and the 3(rd) month using color Doppler imaging. The mean intraocular pressure (IOP) was 22.3 ± 2.1 mmHg at baseline and reduced to 17.4 ± 2.3 mmHg at the 3(rd) month (p < 0.05). None of the retrobulbar parameters, except peak systolic velocity and resistive index in temporal short posterior ciliary arteries, changed significantly on therapy with dorzolamide/timolol fixed combination when the results were analyzed at Month 3. The drug significantly decreased the peak systolic velocity (p = 0.044) and reduced the resistive index in 0.04 units, 95% confidence interval 0.03-0.05, (p < 0.001) in the temporal short posterior ciliary arteries. This study reports that the retrobulbar hemodynamics might be affected less than expected by dorzolamide/timolol fixed combination in patients with PXG although the reduction of IOP was statistically significant.
Keywords: Color Doppler imaging; Dorzolamide/timolol; Glaucoma; Pseudoexfoliation; Retrobulbar ocular blood flow.
Copyright © 2016. Published by Elsevier Taiwan.
Figures


Similar articles
-
Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.Clin Ther. 2008 Jun;30(6):1120-34. doi: 10.1016/j.clinthera.2008.06.006. Clin Ther. 2008. PMID: 18640468 Clinical Trial.
-
A comparison of the long-term effects of dorzolamide 2% and brinzolamide 1%, each added to timolol 0.5%, on retrobulbar hemodynamics and intraocular pressure in open-angle glaucoma patients.J Ocul Pharmacol Ther. 2009 Jun;25(3):239-48. doi: 10.1089/jop.2008.0114. J Ocul Pharmacol Ther. 2009. PMID: 19348600 Free PMC article. Clinical Trial.
-
A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma.J Ocul Pharmacol Ther. 2006 Oct;22(5):353-61. doi: 10.1089/jop.2006.22.353. J Ocul Pharmacol Ther. 2006. PMID: 17076630 Clinical Trial.
-
The effect of timolol-dorzolamide and timolol-pilocarpine combinations on ocular blood flow in patients with glaucoma.Am J Ophthalmol. 2006 Jun;141(6):1158-60. doi: 10.1016/j.ajo.2006.01.050. Am J Ophthalmol. 2006. PMID: 16765700 Clinical Trial.
-
Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.Curr Med Res Opin. 2010 Jun;26(6):1255-67. doi: 10.1185/03007991003738485. Curr Med Res Opin. 2010. PMID: 20350146 Review.
Cited by
-
Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels.Pharmaceutics. 2021 Nov 25;13(12):2010. doi: 10.3390/pharmaceutics13122010. Pharmaceutics. 2021. PMID: 34959292 Free PMC article.
-
Retrobulbar Short Posterior Ciliary Artery Hemodynamics in Patients with Pseudoexfoliation Glaucoma and Primary Open-Angle Glaucoma.J Curr Ophthalmol. 2022 Apr 16;34(1):25-29. doi: 10.4103/joco.joco_59_21. eCollection 2022 Jan-Mar. J Curr Ophthalmol. 2022. PMID: 35620372 Free PMC article.
References
-
- Schlotzer‐Schrehardt U., Naumann G.O.. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006; 141: 921–937. - PubMed
-
- You Q.S., Xu L., Wang Y.X., Yang H., Ma K., Li J.J., et al. Pseudoexfoliation: normative data and associations: the Beijing eye study 2011. Ophthalmology. 2013; 120: 1551–1558. - PubMed
-
- Martinez A., Sanchez M.. Retrobulbar haemodynamic effects of the latanoprost/timolol and the dorzolamide/timolol fixed combinations in newly diagnosed glaucoma patients. Int J Clin Pract. 2007; 61: 815–825. - PubMed
-
- Simsek T., Yanik B., Conkbayir I., Zilelioglu O.. Comparative analysis of the effects of brimonidine and dorzolamide on ocular blood flow velocity in patients with newly diagnosed primary open‐angle glaucoma. J Ocul Pharmacol Ther. 2006; 22: 79–85. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous